Cargando…

Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides

KRAS is a GTPase involved in the proliferation signaling of several growth factors. The KRAS gene is GC-rich, containing regions with known and putative G-quadruplex (G4) forming regions. Within the middle of the G-rich proximal promoter, stabilization of the physiologically active G4(mid) structure...

Descripción completa

Detalles Bibliográficos
Autores principales: Psaras, Alexandra Maria, Valiuska, Simonas, Noé, Véronique, Ciudad, Carlos J., Brooks, Tracy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876201/
https://www.ncbi.nlm.nih.gov/pubmed/35216221
http://dx.doi.org/10.3390/ijms23042097
_version_ 1784658110098440192
author Psaras, Alexandra Maria
Valiuska, Simonas
Noé, Véronique
Ciudad, Carlos J.
Brooks, Tracy A.
author_facet Psaras, Alexandra Maria
Valiuska, Simonas
Noé, Véronique
Ciudad, Carlos J.
Brooks, Tracy A.
author_sort Psaras, Alexandra Maria
collection PubMed
description KRAS is a GTPase involved in the proliferation signaling of several growth factors. The KRAS gene is GC-rich, containing regions with known and putative G-quadruplex (G4) forming regions. Within the middle of the G-rich proximal promoter, stabilization of the physiologically active G4(mid) structure downregulates transcription of KRAS; the function and formation of other G4s within the gene are unknown. Herein we identify three putative G4-forming sequences (G4FS) within the KRAS gene, explore their G4 formation, and develop oligonucleotides targeting these three regions and the G4(mid) forming sequence. We tested Polypurine Reverse Hoogsteen hairpins (PPRHs) for their effects on KRAS regulation via enhancing G4 formation or displacing G-rich DNA strands, downregulating KRAS transcription and mediating an anti-proliferative effect. Five PPRH were designed, two against the KRAS promoter G4(mid) and three others against putative G4FS in the distal promoter, intron 1 and exon 5. PPRH binding was confirmed by gel electrophoresis. The effect on KRAS transcription was examined by luciferase, FRET Melt(2), qRT-PCR. Cytotoxicity was evaluated in pancreatic and ovarian cancer cells. PPRHs decreased activity of a luciferase construct driven by the KRAS promoter. PPRH selectively suppressed proliferation in KRAS dependent cancer cells. PPRH demonstrated synergistic activity with a KRAS promoter selective G4-stabilizing compound, NSC 317605, in KRAS-dependent pancreatic cells. PPRHs selectively stabilize G4 formation within the KRAS mid promoter region and represent an innovative approach to both G4-stabilization and to KRAS modulation with potential for development into novel therapeutics.
format Online
Article
Text
id pubmed-8876201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88762012022-02-26 Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides Psaras, Alexandra Maria Valiuska, Simonas Noé, Véronique Ciudad, Carlos J. Brooks, Tracy A. Int J Mol Sci Article KRAS is a GTPase involved in the proliferation signaling of several growth factors. The KRAS gene is GC-rich, containing regions with known and putative G-quadruplex (G4) forming regions. Within the middle of the G-rich proximal promoter, stabilization of the physiologically active G4(mid) structure downregulates transcription of KRAS; the function and formation of other G4s within the gene are unknown. Herein we identify three putative G4-forming sequences (G4FS) within the KRAS gene, explore their G4 formation, and develop oligonucleotides targeting these three regions and the G4(mid) forming sequence. We tested Polypurine Reverse Hoogsteen hairpins (PPRHs) for their effects on KRAS regulation via enhancing G4 formation or displacing G-rich DNA strands, downregulating KRAS transcription and mediating an anti-proliferative effect. Five PPRH were designed, two against the KRAS promoter G4(mid) and three others against putative G4FS in the distal promoter, intron 1 and exon 5. PPRH binding was confirmed by gel electrophoresis. The effect on KRAS transcription was examined by luciferase, FRET Melt(2), qRT-PCR. Cytotoxicity was evaluated in pancreatic and ovarian cancer cells. PPRHs decreased activity of a luciferase construct driven by the KRAS promoter. PPRH selectively suppressed proliferation in KRAS dependent cancer cells. PPRH demonstrated synergistic activity with a KRAS promoter selective G4-stabilizing compound, NSC 317605, in KRAS-dependent pancreatic cells. PPRHs selectively stabilize G4 formation within the KRAS mid promoter region and represent an innovative approach to both G4-stabilization and to KRAS modulation with potential for development into novel therapeutics. MDPI 2022-02-14 /pmc/articles/PMC8876201/ /pubmed/35216221 http://dx.doi.org/10.3390/ijms23042097 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Psaras, Alexandra Maria
Valiuska, Simonas
Noé, Véronique
Ciudad, Carlos J.
Brooks, Tracy A.
Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title_full Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title_fullStr Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title_full_unstemmed Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title_short Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides
title_sort targeting kras regulation with polypurine reverse hoogsteen oligonucleotides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876201/
https://www.ncbi.nlm.nih.gov/pubmed/35216221
http://dx.doi.org/10.3390/ijms23042097
work_keys_str_mv AT psarasalexandramaria targetingkrasregulationwithpolypurinereversehoogsteenoligonucleotides
AT valiuskasimonas targetingkrasregulationwithpolypurinereversehoogsteenoligonucleotides
AT noeveronique targetingkrasregulationwithpolypurinereversehoogsteenoligonucleotides
AT ciudadcarlosj targetingkrasregulationwithpolypurinereversehoogsteenoligonucleotides
AT brookstracya targetingkrasregulationwithpolypurinereversehoogsteenoligonucleotides